Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs
Status:
Completed
Trial end date:
2018-10-25
Target enrollment:
Participant gender:
Summary
Phase IV 3-Way Double-blind, Randomized, Crossover Study to Compare the Awakening Threshold
Effects (responsivity) of Belsomra 10 mg and 20 mg to Placebo in non-elderly Insomniacs